These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8327848)

  • 1. Cardiovascular risk factors: interactive effects of lipids, coagulation and fibrinolysis.
    Daae LN; Kierulf P; Landaas S; Urdal P
    Scand J Clin Lab Invest Suppl; 1993; 215():19-27. PubMed ID: 8327848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum triglycerides and blood coagulation factors VII and X, and plasminogen activator inhibitor-1.
    Ohni M; Mishima K; Nakajima K; Yamamoto M; Hata Y
    J Atheroscler Thromb; 1995; 2 Suppl 1():S41-6. PubMed ID: 9225231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercoagulability and reduced fibrinolysis in hyperlipidemia: relationship to the metabolic cardiovascular syndrome.
    Andersen P
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S29-31. PubMed ID: 1283767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Tomura S; Nakamura Y; Doi M; Ando R; Ida T; Chida Y; Ootsuka S; Shinoda T; Yanagi H; Tsuchiya S; Marumo F
    Am J Kidney Dis; 1996 Jun; 27(6):848-54. PubMed ID: 8651250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation, fibrinolysis and haemorheology in premenopausal obese women with different body fat distribution.
    Avellone G; Di Garbo V; Cordova R; Raneli G; De Simone R; Bompiani G
    Thromb Res; 1994 Aug; 75(3):223-31. PubMed ID: 7992233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus.
    Juhan-Vague I; Alessi MC; Vague P
    Ann Med; 1996 Aug; 28(4):371-80. PubMed ID: 8862693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low order correlations of lipoprotein(a) with other blood lipids and with coagulation and fibrinolysis parameters in hypertensive and diabetic patients.
    Donders SH; Lustermans FA; van Wersch JW
    Blood Coagul Fibrinolysis; 1992 Jun; 3(3):249-56. PubMed ID: 1386533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension and the metabolic cardiovascular syndrome: special reference to premenopausal women.
    Os I; Nordby G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S15-21. PubMed ID: 1283764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
    Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
    Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of androgens on haemostasis.
    Winkler UH
    Maturitas; 1996 Jul; 24(3):147-55. PubMed ID: 8844628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome.
    Andersen P; Seljeflot I; Abdelnoor M; Arnesen H; Dale PO; Løvik A; Birkeland K
    Metabolism; 1995 May; 44(5):611-6. PubMed ID: 7752909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.
    Meigs JB; Mittleman MA; Nathan DM; Tofler GH; Singer DE; Murphy-Sheehy PM; Lipinska I; D'Agostino RB; Wilson PW
    JAMA; 2000 Jan; 283(2):221-8. PubMed ID: 10634338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
    Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soy protein intake by perimenopausal women does not affect circulating lipids and lipoproteins or coagulation and fibrinolytic factors.
    Dent SB; Peterson CT; Brace LD; Swain JH; Reddy MB; Hanson KB; Robinson JG; Alekel DL
    J Nutr; 2001 Sep; 131(9):2280-7. PubMed ID: 11533267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia.
    Flack JM; Sowers JR
    Am J Med; 1991 Jul; 91(1A):11S-21S. PubMed ID: 1867224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.